ADX-47273
Introduction '''ADX-47273''' is a research pharmaceutical developed by Addex Therapeutics which acts as a positive allosteric modulator (PAM) selective for the metabotropic glutamate receptor subtype mGluR5.It has nootropic and antipsychotic effects in animal studies, and has been used as a lead compound to develop improved derivatives.
See also * Dipraglurant* Raseglurant
References